News

Health Talk: WHO flags RSV deaths in children, calls for new immunisation tools
RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, ...
Fierce Pharma5d
Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
What is RSV and why are infants especially at risk in India?
Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...
It has been a long, deadly flu season in Arizona and the virus is still here
The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...
Baylor College of Medicine19d
For the first time there are safe and effective RSV prevention treatments
Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...
News Medical on MSN12d
World Health Organization (WHO) Outlines Recommendations to Protect Infants Against RSV – Respiratory Syncytial Virus
June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.
Managed Healthcare Executive4d
FDA Approves Enflonsia To Protect Infants During Their First RSV Season
Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.
Hosted on MSN19d
As walking pneumonia rates drop among Canadian children, flu and RSV are back
In infants, the symptoms also include irritability and difficulty breathing. "We are in our RSV season right now in Quebec, with positivity rates over 20 per cent," Papenburg said. Most children ...